Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury

Background and aims: Chronic drug-induced liver injury (DILI) is a rare but under-researched adverse drug reaction–related disease, which is highly likely to progress into liver fibrosis and even cirrhosis. In this study, metabolomics was used to screen out characteristic metabolites related to the...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xian, Zhou, Ming-Xi, Cheng, Cheng, Li, Shan-Shan, Gao, Yuan, Ma, Zhi-Tao, Song, Xin-Hua, Bai, Zhao-Fang, Zou, Zheng-Sheng, Xiao, Xiao-He, Wang, Jia-Bo, Lu, Ya-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163384/
https://www.ncbi.nlm.nih.gov/pubmed/35668948
http://dx.doi.org/10.3389/fphar.2022.896198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163384/
https://www.ncbi.nlm.nih.gov/pubmed/35668948
http://dx.doi.org/10.3389/fphar.2022.896198

Ejemplares similares